UPM Institutional Repository

Platelet profile findings might associate with comorbidities on erectile dysfunction: a cross-sectional study in Indonesia


Citation

Tondohusodo, Samuel Rexy Adrianto and Pasaribu, Wanly Syahrizal and Pakpahan, Cennikon and Rezano, Andri and Supardi, Petrus and Narulita, Pety and Mohd Tamrin, Mohd Islahuddin (2025) Platelet profile findings might associate with comorbidities on erectile dysfunction: a cross-sectional study in Indonesia. Biomolecular and Health Science Journal, 8 (1). pp. 48-53. ISSN 2620-8636

Abstract

Erectile dysfunction (ED) is a prevalent condition with a multifactorial etiology, including vascular, endocrine, neurological, and psychological factors. Platelet indices such as platelet count (PC), mean platelet volume (MPV), and platelet distribution width (PDW) have been studied as potential biomarkers for ED, but findings remain inconsistent. This study aims to investigate the relationship between platelet indices and ED severity and their association with comorbidities. Methods: A cross-sectional observational study was conducted using medical records of ED patients in a single center in Surabaya, Indonesia. Platelet indices, metabolic parameters, and hormone levels were analyzed. ED severity was assessed using the International Index of Erectile Function-5 questionnaire. Statistical analysis included one-way ANOVA or Kruskal–Wallis tests for severity comparisons and t-tests or Mann–Whitney tests for comorbidities. Results: A total of 226 patients were analyzed, with a mean age of 55.37 ± 11.33 years. Severe ED was the most common category (49.11%). No significant differences were found between platelet indices and ED severity (PC: P =0.579, PDW: P =0.758, MPV: P =0.994). However, patients with comorbidities, particularly dyslipidemia and metabolic syndrome, showed significantly higher PC values (P = 0.021 and P = 0.03, respectively). Conclusions: While platelet indices did not correlate with ED severity, PC was significantly associated with ED in patients with metabolic comorbidities. These findings highlight the role of systemic metabolic disturbances in ED pathophysiology, suggesting that comorbidity management may be crucial in ED treatment.


Download File

[img] Text
125556.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike.

Download (1MB)
Official URL or Download Paper: https://journals.lww.com/10.4103/bhsj.bhsj_60_24

Additional Metadata

Item Type: Article
Subject: Medicine
Subject: Biochemistry
Subject: Public Health
Divisions: Faculty of Medicine and Health Science
DOI Number: https://doi.org/10.4103/bhsj.bhsj_60_24
Publisher: Ovid Technologies (Wolters Kluwer Health)
Keywords: Blood biomarkers; Comorbidities; Erectile dysfunction; Hypertension; Metabolic syndrome
Sustainable Development Goals (SDGs): SDG 3: Good Health and Well-being, SDG 10: Reduced Inequalities, SDG 17: Partnerships for the Goals
Depositing User: MS. HADIZAH NORDIN
Date Deposited: 14 May 2026 03:22
Last Modified: 14 May 2026 03:22
Altmetrics: http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.4103/bhsj.bhsj_60_24
URI: http://psasir.upm.edu.my/id/eprint/125556
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item